Aveanna Healthcare Holdings Inc’s recently made public that its Chief Compliance Officer Cunningham Patrick A. unloaded Company’s shares for reported $91174.0 on Jun 13 ’25. In the deal valued at $4.93 per share,18,500 shares were sold. As a result of this transaction, Cunningham Patrick A. now holds 327,869 shares worth roughly $3.06 million.
Then, J.H. Whitney Equity Partners V sold 750,000 shares, generating $3,900,000 in total proceeds. Upon selling the shares at $5.20, the 10% Owner now owns 28,890,756 shares.
Before that, VIGANO PAUL R sold 750,000 shares. Aveanna Healthcare Holdings Inc shares valued at $3,900,000 were divested by the 10% Owner at a price of $5.20 per share. As a result of the transaction, VIGANO PAUL R now holds 28,890,756 shares, worth roughly $269.26 million.
JP Morgan upgraded its Aveanna Healthcare Holdings Inc [AVAH] rating to a Neutral from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who increased its forecast for the stock in mid August from “a Sell” to “a Neutral”. Barclays also remained covering AVAH and has increased its forecast on August 19, 2025 with a “an Overweight” recommendation from previously “an Equal weight” rating. Jefferies revised its rating on July 21, 2025. It rated AVAH as “a Buy” which previously was an “a Hold”.
Price Performance Review of AVAH
On Tuesday, Aveanna Healthcare Holdings Inc [NASDAQ:AVAH] saw its stock jump 5.67% to $9.32. Over the last five days, the stock has gained 9.26%. Aveanna Healthcare Holdings Inc shares have risen nearly 101.73% since the year began. Nevertheless, the stocks have risen 103.94% over the past one year.
How much short interest is there in Aveanna Healthcare Holdings Inc?
A steep rise in short interest was recorded in Aveanna Healthcare Holdings Inc stocks on 2025-09-30, growing by 1.73 million shares to a total of 6.19 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 4.47 million shares. There was a rise of 27.91%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 02, 2025 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $5.50 price target.
